--- title: "ANGIODYNAMICS INC (ANGO) stock: news and investor profile" url: "https://aibio.space/companies/angiodynamics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ANGIODYNAMICS INC (NASDAQ: ANGO), United States. Listing facts, related biotech companies and news on aibio.space." --- ANGO ANGIODYNAMICS INC NASDAQ · United States # ANGIODYNAMICS INC (ANGO) news ANGIODYNAMICS INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ANGO, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest ANGIODYNAMICS INC news We have not published a story on ANGIODYNAMICS INC yet. When there is news, it will appear here. ## ANGIODYNAMICS INC at a glance - **Ticker**: ANGO - **Listing**: NASDAQ - **Country**: United States - **Cash, Aug 31, 2026**: $34.0 million ### Related companies - [CYPHERPUNK TECHNOLOGIES INC.](https://aibio.space/companies/cypherpunk-technologies/) NASDAQ: CYPH - [Freenome](https://aibio.space/companies/freenome/) NASDAQ: FRNM - [ENDRA Life Sciences](https://aibio.space/companies/endra-life-sciences/) NASDAQ: NDRA - [Baird Medical Investment Holdings](https://aibio.space/companies/baird-medical-investment/) NASDAQ: BDMD - [MSA Safety](https://aibio.space/companies/msa-safety/) NYSE: MSA - [Nyxoah SA](https://aibio.space/companies/nyxoah/) NASDAQ: NYXH - [SANUWAVE Health](https://aibio.space/companies/sanuwave-health/) NASDAQ: SNWV - [Zoetis](https://aibio.space/companies/zoetis/) NYSE: ZTS ### Also on NASDAQ - [Opus Genetics](https://aibio.space/companies/opus-genetics/) IRD - [ABVC BioPharma](https://aibio.space/companies/abvc-biopharma/) ABVC - [Mirum Pharmaceuticals](https://aibio.space/companies/mirum-pharmaceuticals/) MIRM - [ArriVent BioPharma](https://aibio.space/companies/arrivent-biopharma/) AVBP - [Aardvark Therapeutics](https://aibio.space/companies/aardvark-therapeutics/) AARD - [PolyPid](https://aibio.space/companies/polypid/) PYPD ## ANGIODYNAMICS INC annual financials | Line | FY ended May 31, 2026 | FY ended May 31, 2025 | |---|---|---| | Research and development | [$29.4 million](https://www.sec.gov/Archives/edgar/data/1275187/000162828026048138/) | [$26.2 million](https://www.sec.gov/Archives/edgar/data/1275187/000162828026048138/) | | Net income (loss) | [-$36.7 million](https://www.sec.gov/Archives/edgar/data/1275187/000114036126037995/) | [-$34.0 million](https://www.sec.gov/Archives/edgar/data/1275187/000114036126037995/) | | Cash from operations | [$3.1 million](https://www.sec.gov/Archives/edgar/data/1275187/000162828026048138/) | [-$10.1 million](https://www.sec.gov/Archives/edgar/data/1275187/000162828026048138/) | | Cash and equivalents | [$53.9 million](https://www.sec.gov/Archives/edgar/data/1275187/000162828026065423/) | [$55.9 million](https://www.sec.gov/Archives/edgar/data/1275187/000162828026048138/) | Latest balance sheet, Aug 31, 2026 (10-Q): cash and equivalents $34.0 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about ANGIODYNAMICS INC What is the ticker symbol of ANGIODYNAMICS INC? ANGIODYNAMICS INC trades under the ticker ANGO on NASDAQ. Where is ANGIODYNAMICS INC listed? ANGIODYNAMICS INC is listed on NASDAQ. Which country or territory is ANGIODYNAMICS INC listed under? Our directory records ANGIODYNAMICS INC under United States. Does aibio.space cover ANGIODYNAMICS INC? aibio.space lists ANGIODYNAMICS INC among 2,820 public biotech companies and publishes its news here as stories appear. Is ANGIODYNAMICS INC profitable? ANGIODYNAMICS INC reported a net loss of $36.7 million for the fiscal year ended May 31, 2026, and generated $3.1 million of cash from operations, per its annual report to the SEC. How much does ANGIODYNAMICS INC spend on research and development? $29.4 million in the fiscal year ended May 31, 2026, per its annual report. How much cash does ANGIODYNAMICS INC have? $34.0 million in cash at Aug 31, 2026, per its 10-Q. ## Investor discussion: ANGIODYNAMICS INC Members talk about ANGIODYNAMICS INC (ANGO). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:ANGO on TradingView](https://www.tradingview.com/symbols/NASDAQ-ANGO/). ## Listing details ANGIODYNAMICS INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ANGO, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: ANGIODYNAMICS INC - **Ticker**: ANGO - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/angiodynamics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "ANGIODYNAMICS INC (ANGO) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/angiodynamics/